GlassScriptPhysician profile
Jeveria Ali
NPI 1396456505
$863.41
in general payments reported to CMS, 2019-2025
21 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $223 · 2024: $167 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $188.62 | 2025 | Tepezza, Otezla, Repatha |
| W. L. Gore & Associates, INC. | $104.12 | 2023-2024 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Edwards Lifesciences Corporation | $69.34 | 2023-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $64.37 | 2023-2025 | |
| Pfizer INC. | $59.35 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.34 | 2025 | Lifevest |
| Novo Nordisk INC | $39.79 | 2023-2025 | Wegovy, Ozempic |
| Averitas Pharma INC. | $31.89 | 2025 | Qutenza |
| Sanofi-Aventis U.S. LLC | $26.75 | 2024 | |
| Lilly USA, LLC | $26.50 | 2025 | Jardiance |
| Philips North America LLC | $25.73 | 2024 | (Ck4) Mcot |
| Tandem Diabetes Care, INC. | $23.90 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Eisai INC. | $23.83 | 2025 | |
| Glaxosmithkline, LLC. | $22.72 | 2025 | Trelegy Ellipta |
| Abbott Laboratories | $21.69 | 2024 | Mitraclip |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $17.78 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16.12 | 2023 | Brilinta |
| Xeris Pharmaceuticals, INC. | $15.96 | 2024 | Gvoke Hypopen |
| Inspire Medical Systems, INC. | $14.60 | 2024 | Inspire |
| Baxter Healthcare | $14.53 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $13.48 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeveria Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.